Workboat Indexes
Press Releases about Immunogen Inc
![](https://mms.businesswire.com/media/20220523005222/en/1463222/5/imgnlogo.jpg)
Advanced Clinical Trials Focus on Development of Vaccines to Prevent Ovarian Cancer Progression
May 18, 2022
Topics
Death
Exposures
Death
![](https://mms.businesswire.com/media/20220510006139/en/1450250/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220506005068/en/1445967/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220502005723/en/1440053/5/imgnlogo.jpg)
![](https://www.financialnewsmedia.com/wp-content/uploads/2020/12/BIOV.small_.jpg)
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://mms.businesswire.com/media/20220421005100/en/1426607/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220401005334/en/1408165/5/imgnlogo.jpg)
From ImmunoGen, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220331005315/en/1406297/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220329005270/en/1403087/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220319005002/en/1394904/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220225005018/en/1371024/5/imgnlogo.jpg)
ImmunoGen Reports Recent Progress and 2021 Financial Results
February 25, 2022
From ImmunoGen Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220223005063/en/1366019/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220215005481/en/1359614/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220210005022/en/1353773/5/imgnlogo.jpg)
From ImmunoGen Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220204005016/en/1346689/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220201005468/en/1345147/5/imgnlogo.jpg)
From ImmunoGen Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220131005121/en/1342961/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220103005412/en/1317123/5/imgnlogo.jpg)
From ImmunoGen Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20211229005002/en/1314584/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20211212005040/en/935398/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20211206005791/en/933420/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20211201006279/en/932412/5/imgnlogo.jpg)
ImmunoGen Announces Pricing of Upsized Public Offering of Common Stock
December 02, 2021
From ImmunoGen Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20211130006063/en/931610/5/imgnlogo.jpg)
ImmunoGen Announces Proposed Public Offering of Common Stock
November 30, 2021
From ImmunoGen Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20211130005310/en/931177/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20211117005358/en/928041/5/imgnlogo.jpg)
ImmunoGen Appoints Tracey L. McCain, Esq. to Its Board of Directors
November 17, 2021
From ImmunoGen Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20211116006082/en/927756/5/imgnlogo.jpg)
From ImmunoGen Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20211116005083/en/927132/5/imgnlogo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.